Dr Jessica Tarn Dr Dennis Lendrem Professor Michael Barnes John Casement Professor Fai Ng et al. | Comorbidities in the UK Primary Sjögren’s Syndrome Registry | 2022 |
|
Dr Philip Shackley Dr Lisa Shaw Dr Christopher Price Professor Michael Barnes Dr Laura Graham et al. | Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin A: results from the botulinum toxin for the upper limb after stroke (BoTULS) trial | 2012 |
|
Professor Michael Barnes
| EPID-based verification of the MLC performance for dynamic IMRT and VMAT | 2012 |
|
Dr Lisa Shaw Dr Christopher Price Frederike Van Wijck Dr Philip Shackley Dr Nick Steen et al. | Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial: Effect on Impairment, Activity Limitation, and Pain | 2011 |
|
Dr Lisa Shaw Professor Michael Barnes Emerita Professor Helen Rodgers
| Response to Letter by Munin et al Regarding Article, "Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial: Effect on Impairment, Activity Limitation, and Pain" | 2011 |
|
Professor Michael Barnes
| Developing core sets for persons with traumatic brain injury based on the international classification of functioning, disability, and health | 2009 |
|
Professor Michael Barnes
| A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force | 2006 |
|
Professor Michael Barnes
| EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force | 2006 |
|
Professor Michael Barnes
| Sativex (R): clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain | 2006 |
|
Dr Anand Pandyan Frederike Van Wijck Professor Garth Johnson Professor Michael Barnes
| The construct validity of a spasticity measurement device for clinical practice: An alternative to the Ashworth scales | 2006 |
|
Professor Michael Barnes
| Are changes in self-reported levels of spasticity on a 0-10 Numerical Rating Scale clinically important? | 2005 |
|
Frederike Van Wijck Professor Michael Barnes
| Botulinum toxin and motor learning: enhancing arm function in patients with chronic spasticity | 2005 |
|
Dr Anand Pandyan Professor Michael Barnes Frederike Van Wijck Professor Garth Johnson
| Spasticity: Clinical perceptions, neurological realities and meaningful measurement | 2005 |
|
Professor Michael Barnes
| The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A - initial experiences | 2005 |
|
Frederike Van Wijck Julie Hooper Professor Michael Barnes Professor Garth Johnson
| [abstract] Improving arm function in patients with chronic spasticity: combining Botulinum Toxin with a task-orientated motor learning programme | 2004 |
|
Jose-de-Jesus Salazar-Torres Dr Anand Pandyan Professor Christopher Price Robert Davidson Professor Michael Barnes et al. | Does spasticity result from hyperactive stretch reflexes? Preliminary findings from a stretch reflex characterization study | 2004 |
|
Professor Michael Barnes
| What drives quality of life in multiple sclerosis? | 2004 |
|
Dr Anand Pandyan Dr Christopher Price Professor Michael Barnes Professor Garth Johnson
| A biomechanical investigation into the validity of the modified ashworth scale as a measure of elbow spasticity | 2003 |
|
Dr Aine Carroll Professor Michael Barnes
| A review of the management of Guillain-Barre syndrome in a regional neurological rehabilitation unit | 2003 |
|
Jose Salazar Torres Dr Anand Pandyan Dr Christopher Price Robert Davidson Professor Michael Barnes et al. | Biomechanical Characterization of the Stretch Reflex Activity as an Approach to Spasticity Measurement and Modeling-A pilot study | 2003 |
|
Professor Michael Barnes
| Botulinum toxin - Mechanisms of action and clinical use in spasticity | 2003 |
|
Professor Michael Barnes
| Community Rehabilitation after Stroke | 2003 |
|
Professor Michael Barnes
| Principles of neurological rehabilitation | 2003 |
|
Professor Michael Barnes Joanna Semlyen Kate McMullen
| Spasticity in multiple sclerosis | 2003 |
|
Jose-de-Jesus Salazar-Torres Dr Anand Pandyan Dr Christopher Price Professor Michael Barnes Professor Garth Johnson et al. | Variations in the stretch reflex excitability due to stretch intensity (torque) in post-stroke and non-impaired volunteers | 2003 |
|
Dr Anand Pandyan Frederike Van Wijck Samantha Stark Professor Garth Johnson Professor Michael Barnes et al. | A simple biomechanically based technique to measure spasticity in routine clinical practice - Results from a preliminary clinical trial | 2002 |
|
Dr Anand Pandyan Frederike Van Wijck Professor Garth Johnson Professor Michael Barnes
| Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox (R) to the elbow flexors in a unilateral stroke population | 2002 |
|
Dr Anand Pandyan Professor Christopher Price Robert Davidson Professor Michael Barnes Professor Garth Johnson et al. | Biomechanical Characterization of Reflex Activity at the Elbow—A First Step to Quantifying Spasticity | 2002 |
|
Professor Michael Barnes
| Measurement of antibodies to Clostridium botulinum neurotoxins, types A-F, in the complexed and uncomplexed forms, in dystonia patients showing secondary resistance to therapy | 2002 |
|
Dr Anand Pandyan Dr Christopher Price Emerita Professor Helen Rodgers Professor Michael Barnes Emeritus Professor Garth Johnson et al. | A quantitative investigation into the construct validity of the modified Ashworth Scale | 2001 |
|
Frederike Van Wijck Dr Anand Pandyan Emeritus Professor Garth Johnson Professor Michael Barnes
| Assessing motor deficits in neurological rehabilitation: a profile of instrument usage | 2001 |
|
Frederike Van Wijck Dr Anand Pandyan Emeritus Professor Garth Johnson Professor Michael Barnes
| Assessing motor deficits in neurological rehabilitation: Patterns of instrument usage | 2001 |
|
Dr Anthony Butler Joanna Semlyen Professor Michael Barnes
| Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: A comparative study between a home and a clinic treatment service | 2001 |
|
Professor Michael Barnes
| Guidance for the preparation of neurological management guidelines by EFNS scientific task forces | 2001 |
|
Dr Anand Pandyan Frederike Van Wijck Samantha Stark Emeritus Professor Garth Johnson Professor Michael Barnes et al. | Is the clinical efficacy of Botulinum Toxin Type A being underestimated in post stroke hemiplegia? | 2001 |
|
Professor Michael Barnes
| Neurological rehabilitation in the community | 2001 |
|
Professor Michael Barnes
| Practical aspects of using botulinum toxin type B | 2001 |
|
Professor Michael Barnes
| Spasticity: A rehabilitation challenge in the elderly | 2001 |
|
Professor Michael Barnes
| Task force on minimum standards for health care of people with multiple sclerosis: June 1999 | 2001 |
|
Professor Michael Barnes Joanna Semlyen
| The establishment of a community multiple sclerosis team | 2001 |
|
Professor Michael Barnes Emeritus Professor Garth Johnson
| Upper Motor Neurone Syndrome and Spasticity | 2001 |
|
Dr Barbara Chandler Professor Michael Barnes
| An epidemiological survey of the health needs of disabled people in a rural community | 2000 |
|
Professor Michael Barnes
| Botulinum toxin (Dysport (R)) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study | 2000 |
|
Dr Elizabeth Davis Professor Michael Barnes
| Botulinum toxin and spasticity | 2000 |
|
Dr Anand Pandyan Professor Garth Johnson Dr Christopher Price Dr Richard Curless Professor Michael Barnes et al. | A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity | 1999 |
|
Professor Michael Barnes
| Rehabilitation after traumatic brain injury | 1999 |
|
Dr Tim Irvine Professor Michael Barnes
| Trust wants help in formulating system to recognise performance of salaried GPs | 1999 |
|